Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniela Pietra

7PUBLICATIONS
64CO-AUTHORS
Liquid biopsiesMolecular targetsCancer diagnosisAutoimmunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.

Nicole S Arellano, William L Heaton, Mirielle C Nauman

|Nov 10, 2022
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.

Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand

|Apr 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.

Juan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz

|Jan 31, 2022
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.

Oscar Borsani, Paul Bastard, Jérémie Rosain

|Dec 22, 2020
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2<sup>P95</sup>-mutated neoplasms.

Gabriele Todisco, Maria Creignou, Anna Gallì

|Oct 14, 2020
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis.

Barbara Mora, Claudia Siracusa, Elisa Rumi

Pageof 2

Frequent Collaborators

6 joint publications

Elisa Rumi

4 joint publications

Ilaria Casetti

2 joint publications

Shannon E Elf

2 joint publications

Paola Guglielmelli

2 joint publications

Nicole S Arellano

2 joint publications

Oscar Borsani

2 joint publications

Michele Ciboddo

2 joint publications

Silvia Catricalà

2 joint publications

Luca Malcovati

2 joint publications

Mario Cazzola

Frequent Collaborators

6 joint publications

Elisa Rumi

4 joint publications

Ilaria Casetti

2 joint publications

Shannon E Elf

2 joint publications

Paola Guglielmelli

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

13.3K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on : Mar 10, 2023

3.7K
See more related videos

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

13.3K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on : Mar 10, 2023

3.7K
See more related videos